Results 161 to 170 of about 115,374 (234)

Obstet Gynecol [PDF]

OBJECTIVE:To estimate expulsion rates among women with postpartum intrauterine device (IUD) placement by timing of insertion, IUD type, and delivery method.DATA SOURCES:We searched PubMed, Cochrane Library, and ClinicalTrials.gov from 1974 to May 2018 ...

core  

The Association Between Menstrual Disorders and Workforce Participation: A Prospective Longitudinal Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 132, Issue 7, Page 961-971, June 2025.
ABSTRACT Objective To assess the association between menstrual disorders and workforce participation among Australian women. Design Population‐based cohort study. Setting Secondary analysis of eight surveys collected between 2000 and 2021. Population A total of 11 152 Australian women, born between 1973 and 1978.
Biresaw Wassihun Alemu, Michael Waller, Leigh R. Tooth   +2 more
wiley   +1 more source

Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers. [PDF]

J Natl Cancer Inst
Tuesley KM, Spilsbury K, Pearson SA, Donovan P, Obermair A, Coory MD, Ali S, Pandeya N, Stewart L, Jordan SJ, Webb PM.   +10 more
europepmc   +1 more source

Magnetic resonance guided high intensity focused ultrasound (MR‐HIFU) effectively reduces fibroid‐related symptoms and improves quality of life—A prospective single‐centre 12‐month follow‐up study

Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 6, Page 1172-1180, June 2025.
MR‐HIFU can offer rapid and sustainable symptom relief for selected symptomatic fibroid patients. The severity of fibroid‐related symptoms was significantly reduced at 3 and 12 months, while the quality of life had increased. In addition, the treatment can be offered to women planning future pregnancies, as no negative effect on future fertility or ...
Saara Otonkoski, Antti Viitala, Gaber Komar, Teija Sainio, Anna Yanovskiy, Roberto Blanco Sequieros, Antti Perheentupa, Kirsi Joronen   +7 more
wiley   +1 more source

Impact of prior levonorgestrel intrauterine device use at the time of embryo transfer. [PDF]

Reprod Fertil
Vanderhoff A, Lanes A, Ginsburg E.
europepmc   +1 more source

Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception. [PDF]

Cochrane Database Syst Rev, 2023
Ramanadhan S, Hansen K, Henderson JT, Cohen MA, Paynter R, Edelman A.   +5 more
europepmc   +1 more source

Atrioventricular conduction abnormalities are associated with poor outcome following intermittent umbilical cord occlusions in fetal sheep

Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 6, Page 1207-1217, June 2025.
Continuous electrocardiographic monitoring of fetal sheep heart during intermittent umbilical cord occlusions gradually leading to severe metabolic acidemia revealed several fetal arrhythmias including atrioventricular block, ventricular tachycardia, and ventricular fibrillation that would have gone unnoticed with current fetal monitoring systems ...
Juulia Lantto, Jonas Johnson, Heikki Huhta, Mervi Haapsamo, Panu Kiviranta, Kati Räsänen, Hanna‐Marja Voipio, Sven‐Erik Sonesson, Juha Voipio, Juha Räsänen, Ganesh Acharya   +10 more
wiley   +1 more source

The Intrauterine Device: How to Deploy This Strategy in the Molecular World? [PDF]

Clin Cancer Res
Johannet P, Friedman CF.
europepmc   +1 more source

Changes in hair cortisol concentration in intrauterine device initiators: A prospective cohort study. [PDF]

Contraception, 2023
Doty N, Beckley E, Garg B, Maristany S, Erikson DW, Jensen JT.   +5 more
europepmc   +1 more source

Development and functional evaluation of recombinant type III collagen intrauterine implant gel. [PDF]

Regen Biomater
Wang X, Fan X, Zhai Y, Li J, Sun H, Li J, Le H, Zhang F, Zhang L, Wang J, Chu Y, Cui P.   +11 more
europepmc   +1 more source